The BAI subfamily of adhesion GPCRs: Synaptic regulation and beyond

Trends in Pharmacological Sciences

Volumn 35, Issue 4, 2014, Pages 208-215

  Stephenson, Jason R ^a   Purcell, Ryan H ^a   Hall, Randy A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiogenesis; brain; G protein coupled receptor; inhibitor; spine; synapse

Indexed keywords

BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 1 PROTEIN; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 2 PROTEIN; BRAIN SPECIFIC ANGIOGENESIS INHIBITOR 3 PROTEIN; G PROTEIN COUPLED RECEPTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIANGIOGENIC ACTIVITY; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; SYNAPSE; SYNAPTIC MEMBRANE;

ANGIOGENESIS; BRAIN; G-PROTEIN-COUPLED RECEPTOR; INHIBITOR; SPINE; SYNAPSE;

ANGIOGENIC PROTEINS; ANIMALS; HUMANS; NERVE TISSUE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SYNAPSES;

EID: 84898832195     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.02.002     Document Type: Review

References (102)

1. K.L. Pierce et al. Seven-transmembrane receptors Nat. Rev. Mol. Cell Biol. 3 2002 639 650
2. D.M. Rosenbaum et al. The structure and function of G-protein-coupled receptors Nature 459 2009 356 363
3. S. Chung et al. Orphan GPCR research Br. J. Pharmacol. 153 Suppl. 1 2008 S339 S346
4. K.J. Paavola, and R.A. Hall Adhesion G protein-coupled receptors: signaling, pharmacology and mechanisms of activation Mol. Pharmacol. 82 2012 777 783
5. T.K. Bjarnadottir et al. The adhesion GPCRs: a unique family of G protein-coupled receptors with important roles in both central and peripheral tissues Cell. Mol. Life Sci. 64 2007 2104 2119
6. S. Yona et al. Adhesion-GPCRs: emerging roles for novel receptors Trends Biochem. Sci. 33 2008 491 500
7. T. Langenhan et al. Sticky signaling - adhesion class G protein-coupled receptors take the stage Sci. Signal. 6 2013 re3
8. D. Arac et al. Dissecting signaling and functions of adhesion G protein-coupled receptors Ann. N. Y. Acad. Sci. 1276 2012 1 25
9. S. Promel et al. Matching structure with function: the GAIN domain of adhesion-GPCR and PKD1-like proteins Trends Pharmacol. Sci. 34 2013 470 478
10. D. Arac et al. A novel evolutionarily conserved domain of cell-adhesion GPCRs mediates autoproteolysis EMBO J. 31 2012 1364 1378
11. J.R. Stephenson et al. Brain-specific angiogenesis inhibitor-1 signaling, regulation, and enrichment in the postsynaptic density J. Biol. Chem. 288 2013 22248 22256
12. S.M. Cork, and E.G. Van Meir Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development J. Mol. Med. (Berl.) 89 2011 743 752
13. D. Park, and K.S. Ravichandran Emerging roles of brain-specific angiogenesis inhibitor 1 Adv. Exp. Med. Biol. 706 2010 167 178
14. B.K. Kay et al. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains FASEB J. 14 2000 231 241
15. T. Shiratsuchi et al. Cloning and characterization of BAI2 and BAI3, novel genes homologous to brain-specific angiogenesis inhibitor 1 (BAI1) Cytogenet. Cell Genet. 79 1997 103 108
16. J.T. Koh et al. Characterization of mouse brain-specific angiogenesis inhibitor 1 (BAI1) and phytanoyl-CoA alpha-hydroxylase-associated protein 1, a novel BAI1-binding protein Brain Res. Mol. Brain Res. 87 2001 223 237
17. J.D. Sokolowski et al. Brain-specific angiogenesis inhibitor-1 expression in astrocytes and neurons: implications for its dual function as an apoptotic engulfment receptor Brain Behav. Immun. 25 2011 915 921
18. K. Mori et al. Brain-specific angiogenesis inhibitor 1 (BAI1) is expressed in human cerebral neuronal cells Neurosci. Res. 43 2002 69 74
19. H.J. Kee et al. Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma FEBS Lett. 569 2004 307 316
20. H.J. Kee et al. Expression of brain-specific angiogenesis inhibitor 2 (BAI2) in normal and ischemic brain: involvement of BAI2 in the ischemia-induced brain angiogenesis J. Cereb. Blood Flow Metab. 22 2002 1054 1067
21. D. Park et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module Nature 450 2007 430 434
22. J.G. Duman et al. The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the recruitment of the Par3/Tiam1 polarity complex to synaptic sites J. Neurosci. 33 2013 6964 6978
23. V. Lanoue et al. The adhesion-GPCR BAI3, a gene linked to psychiatric disorders, regulates dendrite morphogenesis in neurons Mol. Psychiatry 18 2013 943 950
24. W. Wei et al. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene J. Biol. Chem. 282 2007 21729 21737
25. I.E. Deyev, and A.G. Petrenko Regulation of CIRL-1 proteolysis and trafficking Biochimie 92 2010 418 422
26. J.X. Gray et al. CD97 is a processed, seven-transmembrane, heterodimeric receptor associated with inflammation J. Immunol. 157 1996 5438 5447
27. V. Krasnoperov et al. Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif J. Biol. Chem. 277 2002 46518 46526
28. K.E. Volynski et al. Latrophilin fragments behave as independent proteins that associate and signal on binding of LTXN4C EMBO J. 23 2004 4423 4433
29. K.J. Paavola et al. The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity J. Biol. Chem. 286 2011 28914 28921
30. Z. Jin et al. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression Hum. Mol. Genet. 16 2007 1972 1985
31. D. Okajima et al. Brain-specific angiogenesis inhibitor 2 (BAI2) may be activated by proteolytic processing J. Recept. Signal Transduct. Res. 30 2010 143 153
32. S. Promel et al. Characterization and functional study of a cluster of four highly conserved orphan adhesion-GPCR in mouse Dev. Dynam. 241 2012 1591 1602
33. B. Kaur et al. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor Oncogene 24 2005 3632 3642
34. B. Kaur et al. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism Cancer Res. 69 2009 1212 1220
35. X. Piao et al. G protein-coupled receptor-dependent development of human frontal cortex Science 303 2004 2033 2036
36. N. Ke et al. Biochemical characterization of genetic mutations of GPR56 in patients with bilateral frontoparietal polymicrogyria (BFPP) Biochem. Biophys. Res. Commun. 366 2008 314 320
37. N.Y. Chiang et al. Disease-associated GPR56 mutations cause bilateral frontoparietal polymicrogyria via multiple mechanisms J. Biol. Chem. 286 2011 14215 14225
38. S.M. Cork et al. A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1 Oncogene 31 2012 5144 5152
39. H. Nishimori et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis Oncogene 15 1997 2145 2150
40. B. Kaur et al. Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression Am. J. Pathol. 162 2003 19 27
41. D. Zhu et al. Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1 Cancer Res. 71 2011 5859 5870
42. 12/13 and rho pathway J. Biol. Chem. 283 2008 14469 14478
43. R. Luo et al. G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination Proc. Natl. Acad. Sci. U.S.A. 108 2011 12925 12930
44. Y. Ward et al. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells Cancer Res. 71 2011 7301 7311
45. V.G. Lelianova et al. α-Latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptors J. Biol. Chem. 272 1997 21504 21508
46. 2+ and is mediated by latrophilin, G proteins and phospholipase C Philos. Trans. R. Soc. Lond. B: Biol. Sci. 354 1999 379 386
47. s protein J. Biol. Chem. 286 2011 41912 41916
48. J. Gupte et al. Signaling property study of adhesion G-protein-coupled receptors FEBS Lett. 586 2012 1214 1219
49. L. Yang et al. GPR56 regulates VEGF production and angiogenesis during melanoma progression Cancer Res. 71 2011 5558 5568
50. E. Brugnera et al. Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex Nat. Cell Biol. 4 2002 574 582
51. M. Lu, and K.S. Ravichandran Dock180-ELMO cooperation in Rac activation Methods Enzymol. 406 2006 388 402
52. F. de Fraipont et al. Thrombospondins and tumor angiogenesis Trends Mol. Med. 7 2001 401 407
53. D.G. Duda et al. Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis Br. J. Cancer 86 2002 490 496
54. X. Kang et al. Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas Cancer Gene Ther. 13 2006 385 392
55. X.R. Xiao et al. [Therapeutic effect of brain-specific angiogenesis inhibitor 1 on glioblastoma: an animal experiment] Zhonghua Yi Xue Za Zhi 86 2006 1342 1346 (in Chinese)
56. S. Kudo et al. Inhibition of tumor growth through suppression of angiogenesis by brain-specific angiogenesis inhibitor 1 gene transfer in murine renal cell carcinoma Oncol. Rep. 18 2007 785 791
57. K.C. Yoon et al. Lipid-mediated delivery of brain-specific angiogenesis inhibitor 1 gene reduces corneal neovascularization in an in vivo rabbit model Gene Ther. 12 2005 617 624
58. T. Izutsu et al. Brain-specific angiogenesis inhibitor 1 is a putative factor for inhibition of neovascular formation in renal cell carcinoma J. Urol. 185 2011 2353 2358
59. D.W. Dawson et al. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells J. Cell Biol. 138 1997 707 717
60. B. Jimenez et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 Nat. Med. 6 2000 41 48
61. V.A. Fadok et al. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J. Immunol. 148 1992 2207 2216
62. T.L. Gumienny et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration Cell 107 2001 27 41
63. A.E. Hochreiter-Hufford et al. Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion Nature 497 2013 263 267
64. S. Das et al. Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria Proc. Natl. Acad. Sci. U.S.A. 108 2011 2136 2141
65. R.L. Silverstein, and M. Febbraio CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior Sci. Signal. 2 2009 re3
66. J.C. Adams, and R.P. Tucker The thrombospondin type 1 repeat (TSR) superfamily: diverse proteins with related roles in neuronal development Dev. Dynam. 218 2000 280 299
67. K.S. Christopherson et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis Cell 120 2005 421 433
68. C. Eroglu et al. Gabapentin receptor α2δ-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis Cell 139 2009 380 392
69. D.B. Kantor et al. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans Neuron 44 2004 961 975
70. V.Y. Poon et al. UNC-6/netrin and its receptor UNC-5 locally exclude presynaptic components from dendrites Nature 455 2008 669 673
71. I.A. Lim et al. Selectivity and promiscuity of the first and second PDZ domains of PSD-95 and synapse-associated protein 102 J. Biol. Chem. 277 2002 21697 21711
72. A.E. El-Husseini et al. PSD-95 involvement in maturation of excitatory synapses Science 290 2000 1364 1368
73. T. Shiratsuchi et al. Cloning and characterization of BAP3 (BAI-associated protein 3), a C2 domain-containing protein that interacts with BAI1 Biochem. Biophys. Res. Commun. 251 1998 158 165
74. K. Oda et al. Identification of BAIAP2 (BAI-associated protein 2), a novel human homologue of hamster IRSp53, whose SH3 domain interacts with the cytoplasmic domain of BAI1 Cytogenet. Cell Genet. 84 1999 75 82
75. M.A. Abbott et al. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses J. Neurosci. 19 1999 7300 7308
76. J. Bockmann et al. ProSAP/Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53 J. Neurochem. 83 2002 1013 1017
77. J. Choi et al. Regulation of dendritic spine morphogenesis by insulin receptor substrate 53, a downstream effector of Rac1 and Cdc42 small GTPases J. Neurosci. 25 2005 869 879
78. C. Toma et al. Association study of six candidate genes asymmetrically expressed in the two cerebral hemispheres suggests the involvement of BAIAP2 in autism J. Psychiatr. Res. 45 2011 280 282
79. H. Zhang, and I.G. Macara The polarity protein PAR-3 and TIAM1 cooperate in dendritic spine morphogenesis Nat. Cell Biol. 8 2006 227 237
80. D. Okajima et al. Antidepressant-like behavior in brain-specific angiogenesis inhibitor 2-deficient mice J. Physiol. Sci. 61 2011 47 54
81. B.A. Samuels, and R. Hen Neurogenesis and affective disorders Eur. J. Neurosci. 33 2011 1152 1159
82. B.C. Jeong et al. Brain-specific angiogenesis inhibitor 2 regulates VEGF through GABP that acts as a transcriptional repressor FEBS Lett. 580 2006 669 676
83. K. Jin et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo Proc. Natl. Acad. Sci. U.S.A. 99 2002 11946 11950
84. M.F. Bolliger et al. The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins Proc. Natl. Acad. Sci. U.S.A. 108 2011 2534 2539
85. M. Yuzaki Cbln and C1q family proteins: new transneuronal cytokines Cell. Mol. Life Sci. 65 2008 1698 1705
86. T. Iijima et al. Distinct expression of C1q-like family mRNAs in mouse brain and biochemical characterization of their encoded proteins Eur. J. Neurosci. 31 2010 1606 1615
87. J.C. Fiala et al. Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res. Rev. 39 2002 29 54
88. T.A. Blanpied, and M.D. Ehlers Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease Biol. Psychiatr. 55 2004 1121 1127
89. S.A. Irwin et al. Dendritic spine structural anomalies in fragile-X mental retardation syndrome Cereb. Cortex 10 2000 1038 1044
90. R.M. Villalba, and Y. Smith Striatal spine plasticity in Parkinson's disease Front. Neuroanat. 4 2010 133
91. E. Costa et al. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability Neurobiol. Dis. 8 2001 723 742
92. S.J. Russo et al. The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens Trends Neurosci. 33 2010 267 276
93. J.J. Michaelson et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation Cell 151 2012 1431 1442
94. N.P. Tsai et al. Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95 Cell 151 2012 1581 1594
95. P. DeRosse et al. The genetics of symptom-based phenotypes: toward a molecular classification of schizophrenia Schizophr. Bull. 34 2008 1047 1053
96. H.M. Liao et al. Identification and characterization of three inherited genomic copy number variations associated with familial schizophrenia Schizophr. Res. 139 2012 229 236
97. M.J. McCarthy et al. A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response PLoS ONE 7 2012 e32091
98. A. McQuillin et al. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder Pharmacogenet Genomics 17 2007 605 617
99. T. Kenakin, and A. Christopoulos Signalling bias in new drug discovery: detection, quantification and therapeutic impact Nat. Rev. Drug Discov. 12 2013 205 216
100. J.T. Koh et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking αvβ5 integrin Exp. Cell Res. 294 2004 172 184
101. T. Shiratsuchi et al. Cloning and characterization of BAI-associated protein 1: a PDZ domain-containing protein that interacts with BAI1 Biochem. Biophys. Res. Commun. 247 1998 597 604
102. S. Zencir et al. Identification of brain-specific angiogenesis inhibitor 2 as an interaction partner of glutaminase interacting protein Biochem. Biophys. Res. Commun. 411 2011 792 797